How have GNWSF shares performed in 2024?

StageZero Life Sciences' stock was trading at $0.0294 at the start of the year. Since then, GNWSF shares have increased by 32.7% and is now trading at $0.0390. View the best growth stocks for 2024 here .

How do I buy shares of StageZero Life Sciences?

Shares of GNWSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:GNWSF

StageZero Life Sciences (GNWSF) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free GNWSF Stock Alerts

$0.04

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.04
▼
$0.04
50-Day Range: $0.03
▼
$0.04
52-Week Range: $0.00
▼
$1.27

Volume: N/A
Average Volume: 26,719 shs
Market Capitalization: $2.46 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Headlines SEC Filings

Get StageZero Life Sciences alerts:

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About StageZero Life Sciences Stock (OTCMKTS:GNWSF)

StageZero Life Sciences Ltd. develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. It also offers Aristotle, a multi-cancer panel test for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer; and COVID PCR testing and blood test analysis. StageZero Life Sciences Ltd. is headquartered in Richmond Hill, Canada.

GNWSF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

GNWSF Stock News Headlines

April 19, 2024 | bizjournals.com

New report shows sustained growth for Washington's life science industry

April 4, 2024 | theglobeandmail.com

StageZero Life Sciences: Top 10 Undervalued Healthcare Sector Stocks on TSX (SZLS)

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

March 5, 2024 | msn.com

Life Below Zero Season 9 Streaming: Watch & Stream Online via Disney Plus

February 15, 2024 | bizjournals.com

Wu awards $4.7 million to train Bostonians in life sciences industry

February 3, 2024 | msn.com

What Is the Sandwich Generation? Here’s What You Need to Know About This Growing Cohort

November 15, 2023 | finance.yahoo.com

StageZero Life Sciences, Ltd Announces Q3 2023 Financial Results and Operational Update

October 26, 2023 | bizjournals.com

In life sciences, Boston continues to reign supreme

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

October 5, 2023 | bizjournals.com

New York City life-science market ranks among top 10 in country

October 3, 2023 | bizjournals.com

Syneos Health replaces CEO with life sciences veteran Colin Shannon days after $7B deal closes

September 12, 2023 | markets.businessinsider.com

Sustainability, equipment upgrades, and digitalization: big priorities for global pharmaceuticals, life science global study finds

September 11, 2023 | msn.com

Report: Mass. life sciences grew in 'toughest times' in Worcester, Suffolk counties

June 29, 2023 | finance.yahoo.com

Canadian Investment Regulatory Organization Trading Halt - SZLS.WT

June 20, 2023 | finance.yahoo.com

StageZero Life Sciences, Ltd. Announces Temporary Repricing of Warrants Expiring in 2023 and 2024

June 5, 2023 | finance.yahoo.com

StageZero Life Sciences, Ltd. Special and Annual General Meeting Conference Call

May 29, 2023 | msn.com

5 innovators to watch in R.I.’s life sciences industry

May 16, 2023 | msn.com

StageZero Life Sciences Ltd. GAAP EPS of -$0.02, revenue of $0.8M

May 12, 2023 | technews.tmcnet.com

Life Science Instrumentation Market worth $73.9 billion | MarketsandMarkets

April 6, 2023 | bizjournals.com

Demand outstripping construction in L.A.'s life-science real estate market

March 31, 2023 | finance.yahoo.com

StageZero Life Sciences, Ltd Announces Q4 2022 and Year End Financial Results and Operational Update

January 25, 2023 | forbes.com

It's Time For The Life Sciences Industry To Embrace Quality 4.0

January 17, 2023 | nytimes.com

What Happened to All of Science’s Big Breakthroughs?

December 10, 2022 | theglobeandmail.com

StageZero Life Sciences: Bottom 25 Performing Stocks Year-to-Date on TSX (SZLS)

August 18, 2022 | finance.yahoo.com

StageZero Life Sciences Announces Closing of Convertible Debenture Financing

August 17, 2022 | finanznachrichten.de

StageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Q2 2022 Financial Results and Operational Update

August 16, 2022 | seekingalpha.com

StageZero Life Sciences Ltd. (SZLSF) CEO James Howard-Tripp on Q2 2022 Results - Earnings Call Transcript

See More Headlines

Receive GNWSF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Diagnostic Substances
Sub-Industry: N/A
Current Symbol: OTCMKTS:GNWSF
CUSIP: N/A
CIK: 1454263
Web: www.stagezerolifesciences.com
Phone: 905-209-2030
Fax: N/A
Employees: 51
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.28)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-6,860,000.00
Net Margins: -200.26%
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -165.13%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.15
Quick Ratio: 1.08

Sales & Book Value

Annual Sales: $4.15 million
Price / Sales: 0.59
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.02) per share
Price / Book: -1.95

Miscellaneous

Outstanding Shares: 62,995,000
Free Float: N/A
Market Cap: $2.46 million
Optionable: Not Optionable
Beta: 0.28

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. James R. Howard-Tripp
Exec. Chairman & CEO
Mr. Carl Solomon
Interim Chief Financial Officer
Prof. Choong-Chin Liew
Co-Founder
Mr. Warren Whitehead C.M.A. (Age 69)
Chief Accountant
Mr. David Suria
Sr. Scientist

Key Competitors

View All Competitors

GNWSF Stock Analysis - Frequently Asked Questions

How have GNWSF shares performed in 2024?: StageZero Life Sciences' stock was trading at $0.0294 at the start of the year. Since then, GNWSF shares have increased by 32.7% and is now trading at $0.0390.
View the best growth stocks for 2024 here.
How do I buy shares of StageZero Life Sciences?: Shares of GNWSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:GNWSF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial